Saturday, February 22, 2014 9:27:31 AM
GTLLGlobal Technologies, Ltd.
OTC Pink No Information Logo Class A Common Stock OTC Pink No Information 0.00020.00 (0.00%)at Feb 21, 2014Real-Time Best Bid & Ask0.0001 / 0.0002(1 x 1)Why is size 1?
Contact Info
81 Oxford St
London, ENG W1D 2EU
United Kingdom
Phone: +44 207 078 3972
Business Description
GTLL owns several social media and related technolgies for the rapid creation, deployment, and dsitribution of social networking for both personal and business related applications. GTLL/VX Partners' technologies include: GPS auto-checkin locator services for personal and commercial relevance networking, rapid-build social site construction tools for vertical and custom branded market applications for both customer and employee loyalty and incentive programs, personal and enterprise application...
More >>
Verify Company Info Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Mar 12, 2002
Audited Financials Not Available
Latest Report Mar 31, 2011 Quarterly Report
CIK 0000932021
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 6719 - Holding companies, misc
Business Status Development Stage Company a/o Apr 05, 2010
Incorporated In: DE, USA
Year of Inc. 1999
Employees 3 a/o Apr 05, 2010
Company Officers/Contacts
Travis Hoffman Acting CEO
Company Directors
Anthony Welch
Company Notes
•Formerly=Interactive Flight Technologies, Inc. until 10-99
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Recent GTLL News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:45:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/06/2024 10:09:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 02:49:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2024 03:56:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:45:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 02:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:45:16 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:06:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 08:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 01:17:05 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/24/2023 08:39:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 08:27:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM